KLRA
KLRA
Kailera Therapeutics, Inc.
$21.99
+$1.17 (+5.62%)
Mkt Cap: $2.85B
Home / KLRA

Kailera Therapeutics, Inc. (KLRA) Financial Overview

Deep analysis for KLRA is on the way!

Due to high demand, our research team is working through a large queue of in-depth reports. In the meantime, feel free to explore the financial data below. For questions or specific requests, reach out to support@graphvest.com.

KLRA Price Action & Catalysts

Revenue & EPS Trend

Revenue & EPS Growth